Oxford BioMedica's total assets for Q2 2024 were £244.97M, a decrease of -2.92% from the previous quarter. OXBDF total liabilities were £173.75M for the fiscal quarter, a -0.43% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.